On the public citation graph
Restoring invisible and abandoned trials: a call for people to publish the findings
0 signed · 316 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archpsyc.61.11.1153openalex-snapshot
A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial ofParoxetine in Children and Adolescents With Social Anxiety Disorder
inferredcites →https://doi.org/10.1001/jama.1995.03530030045033openalex-snapshot
Nicotine and Addiction
inferredcites →https://doi.org/10.1001/jama.2012.3424openalex-snapshot
Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010
inferredcites →https://doi.org/10.1001/jama.2013.58openalex-snapshot
Restoring Confidence in the Pharmaceutical Industry
inferredcites →https://doi.org/10.1001/jama.274.3.225openalex-snapshot
Nicotine and addiction. The Brown and Williamson documents
inferredcites →https://doi.org/10.1001/jama.278.7.579openalex-snapshot
When authorship fails. A proposal to make contributors accountable
inferredcites →https://doi.org/10.1001/jama.280.21.1831openalex-snapshot
Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus A Randomized Controlled Trial
inferredcites →https://doi.org/10.1001/jama.282.1.31openalex-snapshot
Zanamivir in the Prevention of Influenza Among Healthy Adults
inferredcites →https://doi.org/10.1001/jama.283.8.1016openalex-snapshot
Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza
inferredcites →https://doi.org/10.1001/jama.285.6.748openalex-snapshot
Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts A Randomized Controlled Trial
inferredcites →https://doi.org/10.1001/jama.291.20.2457openalex-snapshot
Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials
inferredcites →https://doi.org/10.1001/jamainternmed.2013.3838openalex-snapshot
The First 2 Years of the European Medicines Agency's Policy on Access to Documents: Secret No Longer
inferredcites →https://doi.org/10.1002/14651858.cd008965.pub3openalex-snapshot
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
inferredcites →https://doi.org/10.1002/14651858.mr000006.pub3openalex-snapshot
Publication bias in clinical trials due to statistical significance or direction of trial results
inferredcites →https://doi.org/10.1002/psb.878openalex-snapshot
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
inferredcites →https://doi.org/10.1016/j.ahj.2004.11.006openalex-snapshot
Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial
inferredcites →https://doi.org/10.1016/j.annemergmed.2005.08.016openalex-snapshot
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction With ST-Segment Elevation
inferredcites →https://doi.org/10.1016/j.clinthera.2007.08.023openalex-snapshot
Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
inferredcites →https://doi.org/10.1016/j.ijantimicag.2009.12.023openalex-snapshot
Safety and pharmacokinetics of oseltamivir at standard and high dosages
inferredcites →https://doi.org/10.1016/j.jad.2008.05.014openalex-snapshot
Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study
inferredcites →https://doi.org/10.1016/j.jamda.2005.08.006openalex-snapshot
Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population
inferredcites →https://doi.org/10.1016/j.jamda.2005.08.007openalex-snapshot
Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population
inferredcites →https://doi.org/10.1016/j.mayocp.2012.02.009openalex-snapshot
Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective
inferredcites →https://doi.org/10.1016/j.pain.2007.12.011openalex-snapshot
Gabapentin in traumatic nerve injury pain: A randomized, double-blind, placebo-controlled, cross-over, multi-center study
inferredcites →https://doi.org/10.1016/j.vaccine.2008.02.068openalex-snapshot
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
inferredcites →https://doi.org/10.1016/j.wneu.2011.08.021openalex-snapshot
Harvey Cushing's Early Treatment of Meningiomas: The Untold Story
inferredcites →https://doi.org/10.1016/s0093-3619(08)70169-2openalex-snapshot
Academic Medical Centers' Standards for Clinical-Trial Agreements With Industry
inferredcites →https://doi.org/10.1016/s0140-6736(00)02288-1openalex-snapshot
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(05)66236-8openalex-snapshot
The signature of responsibility
inferredcites →https://doi.org/10.1016/s0140-6736(05)67660-xopenalex-snapshot
Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(11)60647-8openalex-snapshot
Science as a public enterprise: the case for open data
inferredcites →https://doi.org/10.1016/s0140-6736(96)09457-3openalex-snapshot
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
inferredcites →https://doi.org/10.1016/s0140-6736(98)10190-3openalex-snapshot
Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
inferredcites →https://doi.org/10.1016/s0264-410x(98)00141-8openalex-snapshot
Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks
inferredcites →https://doi.org/10.1016/s0304-3959(02)00255-5openalex-snapshot
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1016/s1073-5437(08)79095-8openalex-snapshot
Gabapentin in traumatic nerve injury pain: A randomized, double-blind, placebo-controlled, cross-over, multi-center study
inferredcites →https://doi.org/10.1016/s1624-5687(05)80227-6openalex-snapshot
Gabapentin for neuropathic cancer pain: a randomized controlled trial from the gabapentin cancer pain study group
inferredcites →https://doi.org/10.1034/j.1399-5618.2000.20305.xopenalex-snapshot
Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1
inferredcites →https://doi.org/10.1038/ki.2012.76openalex-snapshot
The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial
inferredcites →https://doi.org/10.1038/sj.npp.1300960openalex-snapshot
Multiple Dose Pharmacokinetics of Paroxetine in Children and Adolescents with Major Depressive Disorder or Obsessive–Compulsive Disorder
inferredcites →https://doi.org/10.1046/j.1526-4610.2001.111006119.xopenalex-snapshot
Efficacy of Gabapentin in Migraine Prophylaxis
inferredcites →https://doi.org/10.1046/j.1532-5415.2001.49204.xopenalex-snapshot
Long‐Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population
inferredcites →https://doi.org/10.1053/jinf.1999.0602openalex-snapshot
Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study
inferredcites →https://doi.org/10.1056/nejm199709253371302openalex-snapshot
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections
inferredcites →https://doi.org/10.1056/nejm199808273390903openalex-snapshot
The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin
inferredcites →https://doi.org/10.1056/nejm199910283411802openalex-snapshot
Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza
inferredcites →https://doi.org/10.1056/nejm200011023431801openalex-snapshot
Inhaled Zanamivir for the Prevention of Influenza in Families
inferredcites →https://doi.org/10.1056/nejm200111153452023openalex-snapshot
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
inferredcites →https://doi.org/10.1056/nejmc090588openalex-snapshot
Ethical and Scientific Implications of the Globalization of Clinical Research
inferredcites →https://doi.org/10.1056/nejmoa010746openalex-snapshot
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
inferredcites →https://doi.org/10.1056/nejmoa050522openalex-snapshot
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
inferredcites →https://doi.org/10.1056/nejmsa044115openalex-snapshot
Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry
inferredcites →https://doi.org/10.1056/nejmsa065779openalex-snapshot
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
inferredcites →https://doi.org/10.1056/nejmsa0906126openalex-snapshot
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
inferredcites →https://doi.org/10.1056/nejmsa1012065openalex-snapshot
The ClinicalTrials.gov Results Database — Update and Key Issues
inferredcites →https://doi.org/10.1056/nejmsb0803929openalex-snapshot
Ethical and Scientific Implications of the Globalization of Clinical Research
inferredcites →https://doi.org/10.1080/0036554021000026981openalex-snapshot
Zanamivir: a Significant Reduction in Viral Load During Treatment in Military Conscripts with Influenza
inferredcites →https://doi.org/10.1086/313696openalex-snapshot
Short-Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo-Controlled Study
inferredcites →https://doi.org/10.1086/314904openalex-snapshot
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus Infections
inferredcites →https://doi.org/10.1086/345722openalex-snapshot
Zanamivir Prophylaxis: An Effective Strategy for the Prevention of Influenza Types A and B within Households
inferredcites →https://doi.org/10.1086/381128openalex-snapshot
Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis
inferredcites →https://doi.org/10.1089/104454603322126313openalex-snapshot
Impact of Comorbidity on Treatment Response to Paroxetine in Pediatric Obsessive-Compulsive Disorder: Is the Use of Exclusion Criteria Empirically Supported in Randomized Clinical Trials?
inferredcites →https://doi.org/10.1089/cap.2006.16.59openalex-snapshot
An International, Multicenter, Placebo-Controlled Trial of Paroxetine in Adolescents with Major Depressive Disorder
inferredcites →https://doi.org/10.1093/jac/44.suppl_2.23openalex-snapshot
Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis
inferredcites →https://doi.org/10.1097/00004583-200107000-00010openalex-snapshot
Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
inferredcites →https://doi.org/10.1097/00004583-200301000-00007openalex-snapshot
Paroxetine Versus Clomipramine in Adolescents With Severe Major Depression: A Double-Blind, Randomized, Multicenter Trial
inferredcites →https://doi.org/10.1097/00004714-200002000-00006openalex-snapshot
Double-Blind, Placebo-Controlled Study With Reboxetine in Inpatients With Severe Major Depressive Disorder
inferredcites →https://doi.org/10.1097/00004850-199903000-00003openalex-snapshot
Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder
inferredcites →https://doi.org/10.1097/00004850-200301000-00002openalex-snapshot
Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients
inferredcites →https://doi.org/10.1097/00006454-200005000-00005openalex-snapshot
Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial
inferredcites →https://doi.org/10.1097/00006454-200102000-00002openalex-snapshot
Oral oseltamivir treatment of influenza in children
inferredcites →https://doi.org/10.1097/00130535-200511000-00001openalex-snapshot
Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population
inferredcites →https://doi.org/10.1097/00130535-200511000-00002openalex-snapshot
Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population
inferredcites →https://doi.org/10.1097/00132586-199908000-00055openalex-snapshot
Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial
inferredcites →https://doi.org/10.1097/01.chi.0000138356.29099.f1openalex-snapshot
Paroxetine Treatment in Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
inferredcites →https://doi.org/10.1097/01.chi.0000214189.73240.63openalex-snapshot
Paroxetine Treatment in Children and Adolescents With Major Depressive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
inferredcites →https://doi.org/10.1097/01.cot.0000315756.35559.a9openalex-snapshot
Saline Water Being Sold in Counterfeit Neupogen Vials
inferredcites →https://doi.org/10.1097/01.inf.0000154322.38267.ceopenalex-snapshot
Oral Oseltamivir Improves Pulmonary Function and Reduces Exacerbation Frequency for Influenza-Infected Children With Asthma
inferredcites →https://doi.org/10.1097/01.jcp.0000204138.20417.c3openalex-snapshot
Efficacy and Tolerability of Reboxetine Compared with Citalopram
inferredcites →https://doi.org/10.1111/j.1365-2125.1994.tb05705.xopenalex-snapshot
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).
inferredcites →https://doi.org/10.1111/j.1467-8519.2008.01702.xopenalex-snapshot
PUBLICATION ETHICS AND THE GHOST MANAGEMENT OF MEDICAL PUBLICATION
inferredcites →https://doi.org/10.1111/j.1749-6632.1993.tb26343.xopenalex-snapshot
Publication Bias: The Problem That Won't Go Away
inferredcites →https://doi.org/10.1126/science.1203354openalex-snapshot
Making Data Maximally Available
inferredcites →https://doi.org/10.1136/bmj.315.7110.696openalex-snapshot
Authorship is dying: long live contributorship
inferredcites →https://doi.org/10.1136/bmj.326.7400.1171openalex-snapshot
Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications
inferredcites →https://doi.org/10.1136/bmj.b5387openalex-snapshot
Complications: tracking down the data on oseltamivir
inferredcites →https://doi.org/10.1136/bmj.c181openalex-snapshot
Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers
inferredcites →https://doi.org/10.1136/bmj.d7373openalex-snapshot
Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study
inferredcites →https://doi.org/10.1136/bmj.d7898openalex-snapshot
Rethinking credible evidence synthesis
inferredcites →https://doi.org/10.1136/bmj.e7586openalex-snapshot
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
inferredcites →https://doi.org/10.1136/bmj.f2865openalex-snapshot
Restoring invisible and abandoned trials: a call for people to publish the findings
inferredcites →https://doi.org/10.1136/bmjopen-2012-002496openalex-snapshot
Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports
inferredcites →https://doi.org/10.1159/000440849openalex-snapshot
How the Target Hemoglobin of Renal Anemia Should Be?
inferredcites →https://doi.org/10.1159/000455387openalex-snapshot
History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology
inferredcites →https://doi.org/10.1161/circulationaha.107.715821openalex-snapshot
Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children
inferredcites →https://doi.org/10.1163/ej.9789004163300.i-1081.897openalex-snapshot
International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use
inferredcites →https://doi.org/10.1176/appi.ajp.162.7.1351openalex-snapshot
A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
inferredcites →https://doi.org/10.1177/00912700022008900openalex-snapshot
A Population Pharmacokinetic Analysis of Zanamivir in Subjects with Experimental and Naturally Occurring Influenza: Effects of Formulation and Route of Administration
inferredcites →https://doi.org/10.1177/0269881105056666openalex-snapshot
Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine
inferredcites →https://doi.org/10.1177/0306312705052103openalex-snapshot
The Contract Research Organization and the Commercialization of Scientific Research
inferredcites →https://doi.org/10.1177/135965350000500305openalex-snapshot
Oral Oseltamivir in Human Experimental Influenza B Infection
inferredcites →https://doi.org/10.1177/135965359900400202openalex-snapshot
Safety and Efficacy of the Neuraminidase Inhibitor Zanamivir in Treating Influenza Virus Infection in Adults: Results from Japan
inferredcites →https://doi.org/10.1177/14746514040040030601openalex-snapshot
Gabapentin for the treatment of painful diabetic neuropathy: dosing to achieve optimal clinical response
inferredcites →https://doi.org/10.1186/1741-7015-8-18openalex-snapshot
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
inferredcites →https://doi.org/10.1186/1745-6215-11-37openalex-snapshot
Reporting bias in medical research - a narrative review
inferredcites →https://doi.org/10.1186/1745-6215-11-9openalex-snapshot
Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers
inferredcites →https://doi.org/10.1186/1745-6215-12-249openalex-snapshot
Why we need easy access to all data from all clinical trials and how to accomplish it
inferredcites →https://doi.org/10.1200/jco.2004.08.141openalex-snapshot
Gabapentin for Neuropathic Cancer Pain: A Randomized Controlled Trial From the Gabapentin Cancer Pain Study Group
inferredcites →https://doi.org/10.1371/journal.pctr.0010001openalex-snapshot
Principles for Strengthening the Integrity of Clinical Research
inferredcites →https://doi.org/10.1371/journal.pmed.0050217openalex-snapshot
Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
inferredcites →https://doi.org/10.1371/journal.pmed.0050230openalex-snapshot
Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results
inferredcites →https://doi.org/10.1371/journal.pmed.1000251openalex-snapshot
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
inferredcites →https://doi.org/10.1371/journal.pmed.1000335openalex-snapshot
The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
inferredcites →https://doi.org/10.1371/journal.pmed.1001201openalex-snapshot
The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
inferredcites →https://doi.org/10.1371/journal.pmed.1001202openalex-snapshot
Open Clinical Trial Data for All? A View from Regulators
inferredcites →https://doi.org/10.1371/journal.pmed.1001378openalex-snapshot
Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin
inferredcites →https://doi.org/10.1371/journal.pone.0004384openalex-snapshot
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
inferredcites →https://doi.org/10.1377/hlthaff.2011.0172openalex-snapshot
Despite Law, Fewer Than One In Eight Completed Studies Of Drugs And Biologics Are Reported On Time On ClinicalTrials.gov
inferredcites →https://doi.org/10.1542/peds.2009-2628openalex-snapshot
Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
inferredcites →https://doi.org/10.1590/1516-3180.20141324t2openalex-snapshot
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
inferredcites →https://doi.org/10.2165/00044011-200020050-00005openalex-snapshot
Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.2337/diacare.23.11.1605openalex-snapshot
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
inferredcites →https://doi.org/10.3233/jrs-2008-0426openalex-snapshot
Clinical trials and drug promotion: Selective reporting of study 329
inferredcites →https://doi.org/10.3233/jrs-2008-0444openalex-snapshot
Clinical trials and drug promotion: Selective reporting of Study 329
inferredcites →https://doi.org/10.3310/hta14080openalex-snapshot
Dissemination and publication of research findings: an updated review of related biases
inferredcites →https://doi.org/10.4088/jcp.08m04132openalex-snapshot
A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone
inferredcites →https://doi.org/10.4088/jcp.v67n0320openalex-snapshot
A Double-Blind, Randomized, Placebo-Controlled, Prophylaxis Study of Adjunctive Gabapentin for Bipolar Disorder
inferredcites →https://doi.org/10.5860/choice.188906openalex-snapshot
Legacy Tobacco Documents Library
inferredcites →https://doi.org/10.7326/0003-4819-146-6-200703200-00154openalex-snapshot
Reproducible Research: Moving toward Research the Public Can Really Trust
inferredcites →https://doi.org/10.7326/0003-4819-158-3-201302050-00583openalex-snapshot
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4674529openalex-extracted
The Hard Way? Learning and Drug Development Success (or Failure) in the Pharmaceutical Industry
inferred← citeshttps://doi.org/10.1001/jama.2022.16310openalex-snapshot
Screening for Depression and Suicide Risk in Children and Adolescents
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2019.6700openalex-snapshot
Quantifying Sex Bias in Clinical Studies at Scale With Automated Data Extraction
inferred← citeshttps://doi.org/10.1002/14651858.mr000033.pub3openalex-snapshot
Industry sponsorship and research outcome
inferred← citeshttps://doi.org/10.1002/9781119536604.ch4openalex-snapshot
Searching for and selecting studies
inferred← citeshttps://doi.org/10.1002/9781394322183.app2openalex-snapshot
Appendix 2: Initiatives to Improve the Quality of Research
inferred← citeshttps://doi.org/10.1002/acr.24854openalex-snapshot
Extent of and Reasons for Discontinuation and Nonpublication of Interventional Trials on Connective Tissue Diseases: An Observational Study
inferred← citeshttps://doi.org/10.1002/bimj.201300283openalex-snapshot
Sharing clinical trial data on patient level: Opportunities and challenges
inferred← citeshttps://doi.org/10.1002/ehf2.13099openalex-snapshot
Discontinuation and Non-Publication of Heart Failure Randomized Controlled Trials: A Call to Publish All Trial Results
inferred← citeshttps://doi.org/10.1002/jrsm.1277openalex-snapshot
Practical guidance for using multiple data sources in systematic reviews and meta‐analyses (with examples from the MUDS study)
inferred← citeshttps://doi.org/10.1007/978-3-030-15285-7_6openalex-snapshot
Evaluating and Using Medical Evidence in Integrative Mental Health Care: Literature Review, Evidence Tables, Algorithms, and the Promise of Artificial Intelligence
inferred← citeshttps://doi.org/10.1007/978-3-030-86778-2_2openalex-snapshot
The Context and the Problem
inferred← citeshttps://doi.org/10.1007/978-3-030-86778-2_3openalex-snapshot
Secondary Analysis of Individual Patient-Level Clinical Trial Data: A Primer
inferred← citeshttps://doi.org/10.1007/978-3-030-86778-2_6openalex-snapshot
Defining the Intervention Logic of Access-To-Data Measures: A Problem Analysis
inferred← citeshttps://doi.org/10.1007/978-3-031-52013-6_6openalex-snapshot
Bewertung und Nutzung medizinischer Evidenz in der integrativen psychischen Gesundheitsversorgung: Literaturreview, Evidenztabellen, Algorithmen und das Versprechen der künstlichen Intelligenz
inferred← citeshttps://doi.org/10.1007/978-3-319-28731-7_3openalex-snapshot
From Altruists to Workers: What Claims Should Healthy Participants in Phase I Trials Have Against Trial Employers?
inferred← citeshttps://doi.org/10.1007/978-3-319-28731-7_9openalex-snapshot
Fate of Clinical Research Studies After Ethical Approval—Follow-Up of Study Protocols Until Publication
inferred← citeshttps://doi.org/10.1007/978-3-319-52636-2_286openalex-snapshot
Long-Term Management of Data and Secondary Use
inferred← citeshttps://doi.org/10.1007/978-3-319-52677-5_286-1openalex-snapshot
Long-Term Management of Data and Secondary Use
inferred← citeshttps://doi.org/10.1007/978-981-15-1424-1_8openalex-snapshot
Medical Ghost- and Guest-Writing as Corrupt Practices and How to Prevent Them
inferred← citeshttps://doi.org/10.1007/978-981-15-1424-1_9openalex-snapshot
Fraudulent Misrepresentation and Fraudulent Concealment in Products Liability in Tort Law in Canada: The Special Relationship Between Drug Companies and Consumers in the Context of the Fraudulent Misrepresentation and Fraudulent Concealment of Data
inferred← citeshttps://doi.org/10.1007/978-981-96-7959-1_15openalex-snapshot
Innovative Pathways in Natural Polymer-Based Excipients: Shaping the Future of Drug Formulation
inferred← citeshttps://doi.org/10.1007/s00191-015-0439-zopenalex-snapshot
Learning from successes and failures in pharmaceutical R&D
inferred← citeshttps://doi.org/10.1007/s00228-013-1635-0openalex-snapshot
Time to ensure that clinical trial appropriate results are actually published
inferred← citeshttps://doi.org/10.1007/s00590-026-04913-9openalex-snapshot
Discontinuation and nonpublication of osteosarcoma clinical trials: a cross-sectional analysis of ClinicalTrials.gov data
inferred← citeshttps://doi.org/10.1007/s00787-019-01392-8openalex-snapshot
Low dissemination rates, non-transparency of trial premature cessation and late registration in child mental health: observational study of registered interventional trials
inferred← citeshttps://doi.org/10.1007/s11888-014-0234-5openalex-snapshot
Pulmonary Metastasectomy for Colorectal Cancer: Recent Reports Prompt a Review of the Available Evidence
inferred← citeshttps://doi.org/10.1007/s40266-018-0554-2openalex-snapshot
International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action
inferred← citeshttps://doi.org/10.1016/b978-0-08-100616-0.00013-7openalex-snapshot
Why do we need to publish paediatric data?
inferred← citeshttps://doi.org/10.1016/j.antiviral.2021.105158openalex-snapshot
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group
inferred← citeshttps://doi.org/10.1016/j.bcp.2013.10.019openalex-snapshot
Translational paradigms in pharmacology and drug discovery
inferred← citeshttps://doi.org/10.1016/j.canlet.2013.10.010openalex-snapshot
One mouse, one patient paradigm: New avatars of personalized cancer therapy
inferred← citeshttps://doi.org/10.1016/j.healthpol.2016.05.009openalex-snapshot
The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?
inferred← citeshttps://doi.org/10.1016/j.ijcard.2013.08.032openalex-snapshot
2Year follow-up results of the CARDIAC (CARDIomyoplasty by Autologous intraCoronary bone marrow in acute myocardial infarction) randomised controlled trial
inferred← citeshttps://doi.org/10.1016/j.ijcard.2017.12.025openalex-snapshot
Quality of inclusion criteria in the registered clinical trials of heart failure with preserved ejection fraction: Is it time for a change?
inferred← citeshttps://doi.org/10.1016/j.jaac.2020.03.009openalex-snapshot
Editorial: Why JAACAP Published an “Inconclusive” Trial: Optimize, Optimize, Optimize Psychostimulant Treatment
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2016.02.018openalex-snapshot
Evidence selection for a prescription drug's benefit-harm assessment: challenges and recommendations
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2017.05.007openalex-snapshot
Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2018.04.018openalex-snapshot
Randomized controlled trials in pediatric patients had higher completion rates than adult trials: a cross-sectional study
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2023.10.014openalex-snapshot
Harms were detected but not reported in six clinical trials of gabapentin
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2025.111984openalex-snapshot
Reusing clinical trial data to consolidate and advance medical knowledge
inferred← citeshttps://doi.org/10.1016/j.jtos.2015.12.001openalex-snapshot
Product Exclusivity Granted by the U.S. Food and Drug Administration
inferred← citeshttps://doi.org/10.1016/j.jtos.2017.05.009openalex-snapshot
TFOS DEWS II Clinical Trial Design Report
inferred← citeshttps://doi.org/10.1016/j.medcle.2016.12.036openalex-snapshot
The reliability of clinical trials. The risky way towards drug deregulation
inferred← citeshttps://doi.org/10.1016/j.medcli.2014.01.030openalex-snapshot
Acceso público a los resultados de los ensayos clínicos con medicamentos: ¿es esto suficiente para clínicos y pacientes?
inferred← citeshttps://doi.org/10.1016/j.medcli.2016.10.003openalex-snapshot
Fiabilidad de los ensayos clínicos. El peligroso camino de la desregulación de los medicamentos
inferred← citeshttps://doi.org/10.1016/j.ophtha.2016.03.042openalex-snapshot
Re: Li et al.: Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis (Ophthalmology 2016;123:129-40)
inferred← citeshttps://doi.org/10.1016/j.pupt.2019.101883openalex-snapshot
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study
inferred← citeshttps://doi.org/10.1016/s1470-2045(15)70225-1openalex-snapshot
SABR in early operable lung cancer: time for evidence
inferred← citeshttps://doi.org/10.1017/s003329171600324xopenalex-snapshot
Biases in research: risk factors for non-replicability in psychotherapy and pharmacotherapy research
inferred← citeshttps://doi.org/10.1080/17469899.2026.2687161openalex-snapshot
Dissemination pathways and non-publication rates among US-registered retinal vein occlusion trials: a cross-sectional study
inferred← citeshttps://doi.org/10.1089/jop.2015.29004.gdnopenalex-snapshot
Eyes on New Product Development
inferred← citeshttps://doi.org/10.1093/bmb/ldw058openalex-snapshot
The ethics of reporting all the results of clinical trials
inferred← citeshttps://doi.org/10.1093/rescon/vmag025openalex-snapshot
Good science is not only about data: are you asking the right question?
inferred← citeshttps://doi.org/10.1097/01.jaa.0000483095.89264.81openalex-snapshot
How publication bias and inadequate research transparency endanger medicine
inferred← citeshttps://doi.org/10.1097/med.0000000000000065openalex-snapshot
Testosterone and cardiovascular disease
inferred← citeshttps://doi.org/10.1111/1756-2171.12422openalex-snapshot
Does consumer demand pull scientifically novel drug innovation?
inferred← citeshttps://doi.org/10.1111/add.15109openalex-snapshot
Restoring the Bacloville trial: efficacy and harms
inferred← citeshttps://doi.org/10.1111/add.15405openalex-snapshot
Acute impact of self‐guided mental imagery on craving in cocaine use disorder: a mixed‐methods analysis of a randomized controlled trial
inferred← citeshttps://doi.org/10.1111/cts.12087openalex-snapshot
Publishing “Invisible” and “Abandoned” Clinical Trials: A Commitment for CTS
inferred← citeshttps://doi.org/10.1111/dom.71108openalex-snapshot
Mortality in FOURIER Participants With Diabetes: A Regulatory‐Data Reanalysis of Evolocumab Outcomes
inferred← citeshttps://doi.org/10.1111/jep.12843openalex-snapshot
Scientism, conflicts of interest, and the marginalization of ethics in medical education
inferred← citeshttps://doi.org/10.1111/phc3.12352openalex-snapshot
Research gaps in the philosophy of evidence‐based medicine
inferred← citeshttps://doi.org/10.1111/wrr.12237openalex-snapshot
Appropriate analysis and presentation of data in wound healing studies: Should we publish individual patient data?
inferred← citeshttps://doi.org/10.11124/jbisrir-2017-003602openalex-snapshot
The “iceberg” of reporting clinical trials
inferred← citeshttps://doi.org/10.1136/bmj.f3601openalex-snapshot
Restoring the integrity of the clinical trial evidence base
inferred← citeshttps://doi.org/10.1136/bmj.f3857openalex-snapshot
Independent researchers should have right to publish trial results if original researchers don't, campaigners say
inferred← citeshttps://doi.org/10.1136/bmj.f4465openalex-snapshot
How should clinical trial data be shared?
inferred← citeshttps://doi.org/10.1136/bmj.f4794openalex-snapshot
Sharing data from clinical trials: where we are and what lies ahead
inferred← citeshttps://doi.org/10.1136/bmj.f6754openalex-snapshot
Putting GlaxoSmithKline to the test over paroxetine
inferred← citeshttps://doi.org/10.1136/bmj.f7199openalex-snapshot
Who is responsible for publishing the results of old trials?
inferred← citeshttps://doi.org/10.1136/bmj.g171openalex-snapshot
Should journals stop publishing research funded by the drug industry?
inferred← citeshttps://doi.org/10.1136/bmj.g1888openalex-snapshot
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
inferred← citeshttps://doi.org/10.1136/bmj.g2085openalex-snapshot
Operating to remove recurrent colorectal cancer: have we got it right?
inferred← citeshttps://doi.org/10.1136/bmj.g3311openalex-snapshot
Colorectal cancer: a cautionary tale
inferred← citeshttps://doi.org/10.1136/bmj.g4353openalex-snapshot
Inadequacy of remote desktop interface for independent reanalysis of data from drug trials
inferred← citeshttps://doi.org/10.1136/bmj.h4320openalex-snapshot
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
inferred← citeshttps://doi.org/10.1136/bmj.h4601openalex-snapshot
Liberating the data from clinical trials
inferred← citeshttps://doi.org/10.1136/bmj.h4629openalex-snapshot
No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility
inferred← citeshttps://doi.org/10.1136/bmj.h5411openalex-snapshot
Paroxetine and Study 329: what we already knew and when
inferred← citeshttps://doi.org/10.1136/bmj.h6080openalex-snapshot
Why cancer screening has never been shown to “save lives”—and what we can do about it
inferred← citeshttps://doi.org/10.1136/bmj.i65openalex-snapshot
Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports
inferred← citeshttps://doi.org/10.1136/bmj.k1742openalex-snapshot
Restoring biomedical literature with RIAT
inferred← citeshttps://doi.org/10.1136/bmjebm-2018-110979openalex-snapshot
Essential medicines and the challenges in the Evidence-Based Manifesto
inferred← citeshttps://doi.org/10.1136/bmjebm-2018-110993openalex-snapshot
Research integrity and the law that never was
inferred← citeshttps://doi.org/10.1136/bmjebm-2019-111185openalex-snapshot
Institute for Scientific Freedom
inferred← citeshttps://doi.org/10.1136/bmjebm-2019-111331openalex-snapshot
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology
inferred← citeshttps://doi.org/10.1136/bmjebm-2021-111735openalex-snapshot
Transparency of COVID-19 vaccine trials: decisions without data
inferred← citeshttps://doi.org/10.1136/bmjopen-2013-004385openalex-snapshot
The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer
inferred← citeshttps://doi.org/10.1136/bmjopen-2014-005535openalex-snapshot
Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study
inferred← citeshttps://doi.org/10.1136/bmjopen-2014-006666openalex-snapshot
Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting
inferred← citeshttps://doi.org/10.1136/bmjopen-2015-010442openalex-snapshot
How do authors of systematic reviews deal with research malpractice and misconduct in original studies? A cross-sectional analysis of systematic reviews and survey of their authors
inferred← citeshttps://doi.org/10.1136/bmjopen-2017-016040openalex-snapshot
Publication of interventional phase 3 and 4 clinical trials in radiation oncology: an observational study
inferred← citeshttps://doi.org/10.1136/bmjopen-2020-047785openalex-snapshot
Restoring invisible and abandoned trials of gabapentin for neuropathic pain: a clinical and methodological investigation
inferred← citeshttps://doi.org/10.1136/bmjopen-2021-060172openalex-snapshot
Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-063095openalex-snapshot
What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study’s patient-level data with fidelity to the original research protocol
inferred← citeshttps://doi.org/10.1136/medethics-2020-106171openalex-snapshot
Potential for epistemic injustice in evidence-based healthcare policy and guidance
inferred← citeshttps://doi.org/10.1146/annurev-anthro-102116-041539openalex-snapshot
Fluid Drugs: Revisiting the Anthropology of Pharmaceuticals
inferred← citeshttps://doi.org/10.1177/00048674231218623openalex-snapshot
Treatment guesses in the Treatment for Adolescents with Depression Study: Accuracy, unblinding and influence on outcomes
inferred← citeshttps://doi.org/10.1177/0198742917709473openalex-snapshot
Null Effects and Publication Bias in Special Education Research
inferred← citeshttps://doi.org/10.1177/09246479251337879openalex-snapshot
Restoring TADS: RIAT reanalysis of the Treatment for Adolescents with Depression Study
inferred← citeshttps://doi.org/10.1177/1471301214562139openalex-snapshot
Interview with Dr David Healy, 13 February 2013
inferred← citeshttps://doi.org/10.1177/1556264617723137openalex-snapshot
Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research
inferred← citeshttps://doi.org/10.1177/15598276221142307openalex-snapshot
Lifestyle Coaching May Be an Effective Treatment for Schizophrenia
inferred← citeshttps://doi.org/10.1177/2045125320964097openalex-snapshot
Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research
inferred← citeshttps://doi.org/10.1186/s12874-021-01311-zopenalex-snapshot
Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
inferred← citeshttps://doi.org/10.1186/s12874-024-02221-6openalex-snapshot
Reporting of interventional clinical trial results in an academic center: a survey of completed studies
inferred← citeshttps://doi.org/10.1186/s13048-018-0404-1openalex-snapshot
Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar
inferred← citeshttps://doi.org/10.1186/s13063-016-1327-zopenalex-snapshot
Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials
inferred← citeshttps://doi.org/10.1186/s13063-018-2957-0openalex-snapshot
Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
inferred← citeshttps://doi.org/10.1186/s13063-022-07049-3openalex-snapshot
Restoring Study PRGF: a randomized clinical trial on plasma rich in growth factors for knee osteoarthritis
inferred← citeshttps://doi.org/10.1186/s40545-016-0090-6openalex-snapshot
Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency
inferred← citeshttps://doi.org/10.12688/f1000research.6519.1openalex-snapshot
It's never too late to publish an abandoned trial
inferred← citeshttps://doi.org/10.12688/f1000research.6878.1openalex-snapshot
Peering into the “rabbit hole” of publication bias and inadequate research transparency: Adding tangibility to the abstract
inferred← citeshttps://doi.org/10.12688/f1000research.7037.1openalex-snapshot
A call to arms to help heal medicine’s greatest ailment - Publication bias and inadequate research transparency
inferred← citeshttps://doi.org/10.12968/jprp.2025.0137openalex-snapshot
Restoring invisible and abandoned trials
inferred← citeshttps://doi.org/10.1308/147363515x14272809070889openalex-snapshot
Rejected results: Addressing transparency in clinical trials
inferred← citeshttps://doi.org/10.1371/journal.pmed.1001946openalex-snapshot
Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)
inferred← citeshttps://doi.org/10.1371/journal.pmed.1002966openalex-snapshot
Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis
inferred← citeshttps://doi.org/10.1371/journal.pone.0087184openalex-snapshot
Fate of Clinical Research Studies after Ethical Approval – Follow-Up of Study Protocols until Publication
inferred← citeshttps://doi.org/10.1371/journal.pone.0094709openalex-snapshot
Who Has Used Internal Company Documents for Biomedical and Public Health Research and Where Did They Find Them?
inferred← citeshttps://doi.org/10.1371/journal.pone.0108722openalex-snapshot
The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders
inferred← citeshttps://doi.org/10.1371/journal.pone.0110418openalex-snapshot
Why Are Medical and Health-Related Studies Not Being Published? A Systematic Review of Reasons Given by Investigators
inferred← citeshttps://doi.org/10.1371/journal.pone.0149416openalex-snapshot
An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov
inferred← citeshttps://doi.org/10.1371/journal.pone.0167609openalex-snapshot
8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information
inferred← citeshttps://doi.org/10.1371/journal.pone.0189978openalex-snapshot
Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis
inferred← citeshttps://doi.org/10.1371/journal.pone.0195145openalex-snapshot
Conditional equivalence testing: An alternative remedy for publication bias
inferred← citeshttps://doi.org/10.15381/anales.v76i1.11078openalex-snapshot
Recordando a Sir William Osler a 100 años de su fallecimiento: ¿qué podemos aprender de su legado?
inferred← citeshttps://doi.org/10.1542/peds.2016-0223openalex-snapshot
Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3782467/v1openalex-snapshot
Reporting of interventional clinical trial results in a French academic center: a survey of completed studies
inferred← citeshttps://doi.org/10.2217/fon.15.225openalex-snapshot
Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: Is this an Operation that should now be Consigned to History?
inferred← citeshttps://doi.org/10.2217/ica.13.71openalex-snapshot
Patient-level data: a paradigm shift in clinical trial transparency?
inferred← citeshttps://doi.org/10.28938/9780995527775openalex-snapshot
Ghost-Managed Medicine: Big Pharma's Invisible Hands
inferred← citeshttps://doi.org/10.3122/jabfm.2020.04.190199openalex-snapshot
Clinical Decision Support Systems for Opioid Prescribing for Chronic Non-Cancer Pain in Primary Care: A Scoping Review
inferred← citeshttps://doi.org/10.31222/osf.io/4mpucopenalex-snapshot
Proposal to NSF 19-565 to Create a STEM Education Research Hub
inferred← citeshttps://doi.org/10.3233/jrs-160728openalex-snapshot
Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression
inferred← citeshttps://doi.org/10.3233/jrs-200051openalex-snapshot
Extensive selective reporting of quality of life in clinical study reports and publications of placebo-controlled trials of antidepressants
inferred← citeshttps://doi.org/10.3233/jrs-210034openalex-snapshot
Restoring the two pivotal fluoxetine trials in children and adolescents with depression
inferred← citeshttps://doi.org/10.3280/pu2015-004003openalex-snapshot
Problemi della ricerca farmacologica: il caso dello "Studio 329"
inferred← citeshttps://doi.org/10.3280/rsf2016-002002openalex-snapshot
Conoscenze e cultura dell'uso degli psicofarmaci: che cosa si deposita nelle strategie di utilizzo degli psicofarmaci nei servizi di salute mentale?
inferred← citeshttps://doi.org/10.3390/nu15102306openalex-snapshot
Need for Multidimensional and Multidisciplinary Management of Depressed Preadolescents and Adolescents: A Review of Randomized Controlled Trials on Oral Supplementations (Omega-3, Fish Oil, Vitamin D3)
inferred← citeshttps://doi.org/10.3748/wjg.v20.i40.14517openalex-snapshot
History and present status of pulmonary metastasectomy in colorectal cancer
inferred← citeshttps://doi.org/10.4045/tidsskr.20.0254openalex-snapshot
Failure to report results of registered trials of treatments for shoulder complaints
inferred← citeshttps://doi.org/10.4337/9781785363214.00007openalex-snapshot
Critical appraisal: how to examine and evaluate the research evidence
inferred← citeshttps://doi.org/10.5007/2175-8034.2023.e91717openalex-snapshot
Drogas fluidas: revisitando a antropologia dos fármacos
inferred← citeshttps://doi.org/10.51987/evidencia.v19i3.6433openalex-snapshot
Reanálisis del estudio 329: ni eficacia ni seguridad de la paroxetina e imipramina para la depresión mayor en adolescentes
inferred← citeshttps://doi.org/10.51987/evidencia.v19i3.6444openalex-snapshot
La cara oculta del estudio 329 y la manipulación de la evidencia científica
inferred← citeshttps://doi.org/10.5281/zenodo.40330openalex-snapshot
Hypercomplex Analytic Signals : Extension Of The Analytic Signal Concept To Complex Signals
inferred← citeshttps://doi.org/10.5772/intechopen.87201openalex-snapshot
Open Scientific Data - Why Choosing and Reusing the RIGHT DATA Matters
inferred← citeshttps://doi.org/10.5772/intechopen.87631openalex-snapshot
Conclusion: Towards Achievable and Sustainable Open Scientific Data
inferred← citeshttps://doi.org/10.5772/intechopen.91712openalex-snapshot
The Staged Model for Open Scientific Data
inferred← citeshttps://doi.org/10.5772/intechopen.91713openalex-snapshot
Legal Issues Arising in Open Scientific Data
inferred← citeshttps://doi.org/10.5772/intechopen.91714openalex-snapshot
Open Sharing of Clinical Trial Data
inferred← citeshttps://doi.org/10.5772/intechopen.91715openalex-snapshot
Research Data Management at CERN
inferred← citeshttps://doi.org/10.5772/intechopen.91716openalex-snapshot
The Unclear Meaning of Open Scientific Data
inferred← citeshttps://doi.org/10.5772/intechopen.91717openalex-snapshot
The Current Policies of Research Funders and Publishers
inferred← citeshttps://doi.org/10.5772/intechopen.91718openalex-snapshot
The Case for Open Scientific Data: Theory, Benefits, Costs and Opportunities
inferred← citeshttps://doi.org/10.5772/intechopen.91719openalex-snapshot
Introduction: Opening Up Data in Scientific Research
inferred← citeshttps://doi.org/10.6084/m9.figshare.14741249openalex-snapshot
Additional file 2 of Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
inferred← citeshttps://doi.org/10.6084/m9.figshare.25670132openalex-snapshot
Additional file 1 of Reporting of interventional clinical trial results in an academic center: a survey of completed studies
inferred← citeshttps://doi.org/10.7202/1026134aropenalex-snapshot
Decreasing the Data Deficit: Improving Post-Market Surveillance in Pharmaceutical Regulation
inferred← citeshttps://doi.org/10.7205/milmed-d-15-00517openalex-snapshot
Publishing Military Medical Research: Appreciating the Process
inferred← citeshttps://doi.org/10.7326/m14-0933openalex-snapshot
Financial Conflicts of Interest and Conclusions About Neuraminidase Inhibitors for Influenza
showing the first 182 of 183 · page through all 183
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.